Functional diagnostics of the respiratory system in patients with Long COVID
DOI:
https://doi.org/10.61751/bmbr.2706-6290.2023.2.60Keywords:
spirometry, pulmonary function tests, COVID, walk testAbstract
Given the considerable number of people with persistent respiratory symptoms more than 4 weeks after
COVID-19, it is important to determine which examinations are most informative for assessing respiratory function,
prognosis, and monitoring the effectiveness of treatment in such patients. The purpose of this study is to cover the
functional diagnosis of the respiratory system in patients who survived Long COVID. Bibliosemantic and analytical
research methods were applied. According to the world guidelines for patients with persistent respiratory symptoms
after COVID-19, all of them should undergo respiratory system examinations: chest X-rays, spirometry, blood saturation
measurements, lung diffusion capacity for carbon monoxide, walk tests, and others. The study confirmed that people
who have had COVID-19, even after 1-6 months, show a decrease in diffusing capacity of the lung for carbon monoxide,
which has a direct correlation with total lung capacity, the severity of clinical manifestations, and the results of rapid
tests. Changes in spirometric parameters are observed much less frequently, mainly in patients hospitalised with severe
pneumonia, which subsequently leads to post-cystic pulmonary fibrosis. Gradual improvement in functional respiratory
tests occurs 3 months, 6 months, and 12 months after acute infection. The most informative tests for assessing respiratory
function include the measurement of carbon monoxide diffusion capacity, total lung capacity, and blood gas composition.
In conditions of limited access to the aforementioned diagnostic tests, and as a screening tool, quick tests such as the
3-minute/6-minute walk test (3MWT/6MWT) or the 1-minute sit-to-stand test (1-MSTST) can be utilised based on the
patient's capabilities
Received: 29.03.2023 | Revised: 27.05.2023 | Accepted: 26.06.2023
References
Mahase E. Covid-19: What Do We Know about “Long Covid”? BMJ. 2020 Jul 14;370:m2815. DOI: 10.1136/bmj.m2815
National Commissioning Guidance for Post-COVID Services. Version 3, July 2022. Available from: https://www.england.nhs.uk/wp-content/uploads/2022/07/C1670_National-commissioning-guidance-for-post-COVID-services_ V3_July-2022-1.pdf
Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid—an update for primary care. BMJ. 2022;378:e072117. DOI: 10.1136/bmj-2022-072117
Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ‘Long-COVID’: A cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021 Apr;76(4):396–98. DOI: 10.1136/thoraxjnl-2020-215818
Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Long COVID and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Nat Med. 2021 Mar 22; 27: 601–15. DOI: 10.1038/s41591-021-01283-z
Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020 Jul 13;24(1):422. DOI: 10.1186/s13054-020-03120-0
Lutchmansingh DD, Knauert MP, Antin-Ozerkis DE, et al. A clinic blueprint for post-coronavirus disease 2019 recovery: Learning from the past, looking to the future. Chest. 2021 Mar;159(3):949–58. DOI: 10.1016/j.chest.2020.10.067
Izmailova ES, Reiss TF. Reiss Closer to the patient means better decisions: Wearable remote monitoring of patients with COVID-19 lung disease. Clin Transl Sci. 2021 Nov;14(6):209–94. Published online 2021 Jun 30. DOI: 10.1111/ cts.13085
Radovanovic D, D’Angelo E. Lung pathophysiology in patients with long COVID-19: One size definitely does not fit all. ERJ Open Res. 2023;9(1):00052-2023. DOI: 10.1183/23120541.00052-2023
Guziejko K, Moniuszko-Malinowska A, Czupryna P, Dubatówka M, Łapińska M, Raczkowski A, et al. Assessment of pulmonary function tests in COVID-19 convalescents six months after infection. J Clin Med. 2022;11(23):7052. DOI: 10.3390/jcm11237052
Funke-Chambour M, Bridevaux PO, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C, et al. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration. 2021;100(8):826–41. DOI: 10.1159/000517255
NHS England. National commissioning guidance for post COVID services. Published July 28, 2022. Updated July 28, 2022. 39 pages. Available from: https://www.england.nhs.uk/publication/national-commissioning-guidance-forpost-covid-services/
Antoniou KM, Vasarmidi E, Russell AM, Andrejak C, Crestani B, Delcroix M, et al. European Respiratory Society statement on long COVID follow-up. Eur Respir J. 2022 Aug 4;60(2):2102174. DOI: 10.1183/13993003.02174-2021
Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society Technical Statement. Am J Respir Crit Care Med. [Internet]. [cited 2023 May 12];200(8). Available from: https://doi.org/10.1164/rccm.201908-1590ST
McGowan A, Laveneziana P, Bayat S, Beydon N, Boros PW, Burgos F, et al. International consensus on lung function testing during the COVID-19 pandemic and beyond. ERJ Open Res. 2022;8(1):00602-2021. DOI: 10.1183/23120541. 00602-2021
Bakalets OV, Behosh NB, Dzyha SV, Zaiets TA. Modern requirements for spirometry [in Ukrainian]. Bull Med Biol Res. 2019;(2):57–64. DOI: 10.11603/bmbr.2706-6290.2019.2.10605
Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022;60:2101499. DOI: 10.1183/13993003.01499-2021
Vogelmeier C, Augusty A, Anzueto A. GOLD Scientific Committee. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2023 Report. [Internet]: GOLD; [cited 2023 Feb 25]. Available from: https://goldcopd.org/2023-gold-report-2/
Krueger T, van den Heuvel J, van Kampen-van den Boogaart V, van Zeeland R, Mehagnoul-Schipper DJ, Barten DG, et al. Pulmonary function three to five months after hospital discharge for COVID-19: A single centre cohort study. Sci Rep. 2023;13:681. DOI: 10.1038/s41598-023-27879-8
Javaherian M, Shadmehr A, Keshtkar A, Beigmohammadi MT, Dabbaghipour N, Syed A, et al. Safety and efficacy of pulmonary physiotherapy in hospitalized patients with severe COVID-19 pneumonia (PPTCOVID study): A prospective, randomised, single-blind, controlled trial. PLoS One. 2023 Jan 31;18(1):e0268428. DOI: 10.1371/journal. pone.0268428
Cortes-Telles A, Lopez-Romero S, Figueroa-Hurtado E, PouAguilar YN, Wong AW, Milne KM, et al. Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. 2021 Jun;288:103644. DOI: 10.1016/j.resp.2021.103644
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373. DOI: 10.1136/bmj.n1098
Ekborn E, Frithiof R, Emilsson Öi, Larson Im, Lipcsey M, Rubertsson S, et al. Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge. Respir Med. 2021 Jun;182:106394. DOI: 10.1016/j.rmed.2021.106394
Lehmann A, Gysan M, Bernitzky D, Bal C, Prosch H, Zehetmayer S, et al. Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19. BMC Pulm Med. 2022;22:196. DOI: 10.1186/s12890-022-01987-z
Chun HJ, Coutavas E, Pine A, Lee AI, Yu V, Shallow M, et al. Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). medRxiv. 2021 Apr 21;2021.01.31.21250870. DOI: 10.1101/2021.01.31.21250870
Okan S, Okan F, Duran Yücesoy F. Evaluation of pulmonary function and exercise capacity after COVID-19 pneumonia. Heart Lung. 2022 Jul-Aug;54:1–6. DOI: 10.1016/j.hrtlng.2022.03.004
Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun 18;55(6):2001217. DOI: 10.1183/13993003.01217-2020
Blanco JR, Cobos-Ceballos MJ, Navarro F, Sanjoaquin I, Arnaiz de Las Revillas F, Bernal E, et al. Pulmonary longterm consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021 Jun;27(6):892–96. DOI: 10.1016/j.cmi.2021.02.019
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir Med. 2021 Jul;9(7):747–54. DOI: 10.1016/S2213-2600(21)00174-0
Zhang H, Li X, Huang L, Gu X, Wang Y, Liu M, et al. Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort study. EClinicalMedicine. 2022 Sep 28;54:101668. DOI: 10.1016/j.eclinm.2022.101668
Kammin EJ. The 6-minute walk test: Indications and guidelines for use in outpatient practices. J Nurse Pract. 2022 Jun;18(6):608–10. DOI: 10.1016/j.nurpra.2022.04.013
Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/ American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur Respir J. 2014 Dec;44(6):1428–46. DOI: 10.1183/09031936.00150314
Spruit MA, Holland AE, Singh SJ, Tonia T, Wilson KC, Troosters T. COVID-19: Interim guidance on rehabilitation in the hospital and post-hospital phase from a European respiratory society and American thoracic society-coordinated international task force. Eur Respir J. 2020 Aug 13;56(6):2002197. DOI: 10.1183/13993003.02197-2020
Eksombatchai D, Wongsinin T, Phongnarudech T, Thammavaranucupt K, Amornputtisathaporn N, Sungkanuparph S. Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study. PLoS One. 2021 Sep 2;16(9):e0257040. DOI: 10.1371/journal.pone.0257040
Wong AW, López-Romero S, Figueroa-Hurtado E, Vazquez-Lopez S, Milne KM, Ryerson CJ, et al. Predictors of reduced 6-minute walk distance after COVID-19: A cohort study in Mexico. Pulmonology. 2021 Nov-Dec;27(6):563–65. DOI: 10.1016/j.pulmoe.2021.03.004
Bohannon RW, Crouch R. 1-Minute sit-to-stand test: Systematic review of procedures, performance, and clinimetric properties. J Cardiopulm Rehabil Prev. 2019 Jan;39(1):2–8. DOI: 10.1097/HCR.0000000000000336
Kalin A, Javid B, Knight M, Inada-Kim M, Greenhalgh T. Direct and indirect evidence of efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: A rapid systematic review. Syst Rev. 2021;10:77. DOI: 10.1186/ s13643-021-01620-w
Sevillano-Castaño A, Peroy-Badal R, Torres-Castro R, Gimeno-Santos E, García Fernández P, Garcia Vila C, et al. Is there a learning effect on 1-min sit-to-stand test in post-COVID-19 patients? ERJ Open Res. 2022;8:00189-2022. DOI: 10.1183/23120541.00189-2022
Flampouraris V, Kalinoglou S, Kandreviotou S, Raitsiou B, Kokolaki M, Tsiafaki X. Assessment of dyspnoea in Covid 19 patients using modified Borg scale. Signa Vitae. 2021;17(S1):37–37. DOI: 10.22514/sv.2021.182
Tobase L, Peres HHC, Polastri TF, Cardoso SH, Souza DR, Almeida DG, Timerman S. The use of the Borg rating of perceived exertion scale in cardiopulmonary resuscitation. Arq Bras Cardiol. 2023;120(1):e20220240. DOI: 10.36660/ abc.20220240
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bulletin of Medical and Biological Research

This work is licensed under a Creative Commons Attribution 4.0 International License.











